Page 172 - Haematologica March 2020

M. Xu et al.
39. Naka K, Hoshii T, Muraguchi T, et al. TGF-
beta-FOXO signalling maintains leukaemia- initiating cells in chronic myeloid leukaemia. Nature. 2010; 463(7281):676-680.
40. Xiang W, Jiang T, Guo F, et al. Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by dis- turbing tumor ciliogenesis. Oncol Rep. 2014;32(4):1622-1630.
41. Liu M, Wang S, Clampit JE, et al. Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies. Bioorg Med Chem Lett. 2007;17(3):668-672.
42. Lin JH, Zhang JJ, Lin S-L, Chertow GM. Design of a Phase 2 Clinical trial of an ASK1 inhibitor, GS-4997, in patients with diabetic kidney disease. Nephron. 2015; 129(1):29- 33.
43.
44.
45.
46.
Volynets GP, Chekanov MO, Synyugin AR, et al. Identification of 3H-Naphtho 1,2,3-de quinoline-2,7-diones as inhibitors of apopto- sis signal-regulating kinase 1 (ASK1). J Med Chem. 2011;54(8):2680-2686.
Zeng Q, Wang J, Cheng Z, et al. Discovery and evaluation of clinical candidate AZD3759, a potent, oral active, central nerv- ous system-penetrant, epidermal growth factor receptor tyrosine kinase Inhibitor. J Med Chem. 2015;58(20):8200-8215.
Tan F, Shen X, Wang D, et al. Icotinib (BPI- 2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclin- ical studies. Lung Cancer. 2012; 76(2):177- 182.
Hyman JM, Firestone AJ, Heine VM, et al. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade.
Proc Natl Acad Sci U S A. 2009; 106(33):
14132-14137.
47. Redig AJ, Vakana E, Platanias LC. Regulation
of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR-ABL. Leuk Lymphoma. 2011;52 suppl 1:45-53.
48. Bellazzo A, Di Minin G, Collavin L. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer. Cell Death Differ. 2017;24(1):15-25.
49. Corrado C, Saieva L, Raimondo S, Santoro A, De Leo G, Alessandro R. Chronic myel- ogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. J Cell Mol Med. 2016;20(10): 1829-1839.
686
haematologica | 2020; 105(3)